‘Overpriced’ virus tests: Duterte wants answers
President Rodrigo Duterte wants an investigation of the allegedly overpriced COVID-19 tests to be paid by the Philippine Health Insurance Corp. (PhilHealth), which a Senate inquiry had uncovered.
Presidential spokesperson Harry Roque said Mr. Duterte was “bothered” by the price difference between the testing costs cited by PhilHealth and the private sector.
The alleged test overprice was pointed out this week by both Sen. Panfilo Lacson and Senate Minority Leader Franklin Drilon.
“When the private sector bought test kits, it’s P1,750,000. But when the government buys it, it’s P4 million. So he wants an answer and an investigation,” Roque said. “Like the rest of the nation, he could not understand why the discrepancy is so huge.”
Roque was referring to the Sansure Natch CS Fully Automated Nucleic Acid Extraction System purchased by the private sector for Project ARK (antibody rapid test kits) priced at P1.75 million per unit and the Thermo Scientific King Fisher Flex Automated Nucleic Acid Extraction Machine, amounting to P4 million per unit. The overprice was flagged by Lacson during the Senate committee of the whole hearing on Tuesday.
Lacson also questioned the $32 price tab of the government-procured swabbing system compared with the $16 purchased by the private sector.
Drilon on Thursday said PhilHealth had earmarked P8,150 per test, but paid the Philippine Red Cross only P3,500 for the same procedure.
The tests are intended to determine whether a person was infected with SARS-CoV-2, the virus that causes the severe respiratory disease.
Health Secretary Francisco Duque III had clarified that the cost of testing package to be shouldered by PhilHealth actually ranged from P2,710 to P8,150.
If the test was not paid by the Department of Health (DOH) and the test kit used was not donated, the total cost wold be P8,150. PhilHealth will pay only P2,710 if the test is shouldered by the DOH and if the test kit is donated, he said.
Duque said that if the procedure was not paid by the DOH but the test kit was donated, the price would be P5,450 per test.
Roque said he would give transcripts of the Senate hearing and other documents to Undersecretary Jesus Melchor Quitain, the officer in charge of the Office of the Special Assistance to the President.
In a statement on Friday, Drilon said PhilHealth already released P30 billion in advance payments to hospitals attending to COVID-19 patients.
He said this contradicted the assurances made by PhilHealth president Ricardo Morales to senators on Wednesday that the state health insurer had made no actual payments connected to COVID-19 cases.
The opposition senator said the payments were made through PhilHealth’s Interim Reimbursement Mechanism (IRM).Quoting the agency’s website, he said the IRM was intended to help medical facilities “respond to the onslaught of COVID-19 in the country.”
“IRM is a ‘prepaid’ system. Before this latest development, accredited hospitals were already charging to the downloaded fund the cost of testing at a price tag of P8,150,” Drilon said.
“The amount … is equivalent to three months’ worth of claims based on historical data, which will be charged to their future claims,” he added.
Since the government was aiming to test 2 million Filipinos, Drilon said at least P8.3 billion in taxpayer money could have been wasted.
A PhilHealth press statement on April 14 said “ground zero hospitals” had already received P1.6 billion of the P30 billion under the IRM.
“The IRM is PhilHealth’s financial aid to its partner health institutions affected by natural and man-made calamities that have devastating effects on their ability to continuously provide health care to the people,” PhilHealth said.
‘Only P13B released’
Speaking to senators in a video conference on Wednesday, Morales said PhilHealth had not approved payments for COVID-19 tests.
On Friday, Morales told the Inquirer that “only about P13 billion [had] actually [been] released and will still be liquidated submitting proof of purchase of test kits and [personal protective equipment].”
“No liquidation so far,” he added.
Following accounting procedures, hospitals or health-care facilities will submit a liquidation document listing expense items that they had charged to PhilHealth. After examining the document, the agency may opt to disallow certain charges.
PhilHealth on Thursday announced it would reduce by nearly 50 percent the cost of COVID-19 test to P4,210.
Drilon welcomed the agency’s decision, calling it “a victory for better governance and anticorruption drive.”
“This should be a lesson to PhilHealth and the government in general: We are watching you,” he said.
Drilon said bringing down the cost of the test package would help the government to test more people for free.
“Why would PhilHealth have different prices for the same test? I am glad that PhilHealth listened to us,” he said, adding: “PhilHealth should look at lowering it to P3,500 or perhaps even lower. I have heard that some institutions can do it at as low as P2,000.” —WITH A REPORT FROM JOVIC YEE
Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.